×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| PANACEA BIOTEC LTD. | 1117.5 | 96.5 | 1084.3 | 1.58 | 1,985 | |
| DR.AGARWALS EYE HOSPITAL LTD. | 974.20 | 104.00 | 951.10 | 22.13 | 1948 | 37.8 |
| SMS PHARMACEUTICALS LTD. | 1,754.81 | 182.42 | 1,733.53 | 2.15 | 1816 | 27.5 |
Panacea Biotec Ltd., with Security Code 531349, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 48.7 | 71.9 | 75.0 | 89.4 | 94.5 | 95.2 | 80.3 | 56.8 | 76.6 | 108.4 |
| Expenses | 55.1 | 59.7 | 71.6 | 82.6 | 84.6 | 88.6 | 89.6 | 67.4 | 69.9 | 93.0 |
| Operating Profit | -6.3 | 12.3 | 3.4 | 6.8 | 10.0 | 6.6 | -9.2 | -10.5 | 6.7 | 15.4 |
| OPM % | -12.97% | 17.08% | 4.57% | 7.62% | 10.53% | 6.97% | -11.5% | -18.44% | 8.79% | 14.19% |
| Other Income | 7.9 | 9.7 | 10.3 | 3.3 | 2.1 | 3.1 | 16.4 | 3.8 | 3.4 | 3.3 |
| Interest | 2.2 | 2.7 | 2.7 | 3.5 | 3.6 | 3.4 | 3.4 | 3.2 | 3.8 | 3.9 |
| Depreciation | 6.2 | 6.1 | 5.9 | 5.4 | 5.3 | 5.2 | 5.1 | 5.1 | 5.1 | 5.2 |
| Profit before tax | -6.9 | 13.2 | 5.1 | 1.3 | 3.2 | 1.1 | -1.4 | -15.0 | 1.3 | 9.7 |
| Tax % | 0% | 0% | 486.1% | 0% | 0% | 59.8% | -1.5% | -8% | 0.8% | 0% |
| Net Profit | -6.9 | 13.2 | -19.7 | 1.3 | 3.2 | 0.4 | -1.4 | -13.8 | 1.3 | 9.7 |
| EPS in Rs | -1.12 | 2.16 | -3.21 | 0.21 | 0.52 | 0.07 | -0.22 | -2.25 | 0.21 | 1.58 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 110.7 | 105.1 | 115.2 | 128.9 | 129.2 | 143.0 | 150.5 | 136.5 | 115.7 | 147.4 |
| Expenses | 190.5 | 109.0 | 123.8 | 134.6 | 139.5 | 146.6 | 150.7 | 142.5 | 129.7 | 140.4 |
| Operating Profit | -79.8 | -3.8 | -8.6 | -5.7 | -10.3 | -3.6 | -0.2 | -6.0 | -14.0 | 7.0 |
| OPM % | -72.1% | -3.7% | -7.5% | -4.4% | -8% | -2.5% | -0.1% | -4.4% | -12.1% | 4.8% |
| Other Income | 40.0 | 38.2 | 41.7 | 34.4 | 33.8 | 6.0 | 8.5 | 13.6 | 6.5 | 7.4 |
| Interest | 1.3 | 1.2 | 1.0 | 1.1 | 1.0 | 0.9 | 0.9 | 0.8 | 0.9 | 1.0 |
| Depreciation | 10.1 | 9.9 | 9.7 | 9.5 | 9.5 | 9.3 | 9.1 | 8.8 | 8.7 | 8.7 |
| Profit before tax | -78.9 | -4.5 | -5.3 | -1.2 | -14.7 | -10.6 | -4.4 | -4.9 | -19.8 | 2.0 |
| Tax % | -9.7% | 32.6% | 13.7% | 169.6% | 15.7% | -6.6% | -33.3% | -6.1% | -6.9% | 1.1% |
| Net Profit | -56.1 | 15.7 | 19.4 | -12.7 | 11.0 | -8.3 | -2.2 | -2.0 | -15.9 | 4.7 |
| EPS in Rs | -9 | 2 | 3 | -2 | 1 | -1 | 0 | 0 | -2 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 30% |
| 3 Years: | 2% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 15% |
| 3 Years: | 30% |
| TTM: | 72% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 26% |
| 3 Years: | 18% |
| 1 Year: | 99% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 4% |
| 3 Years: | -4% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 26% |
| 3 Years: | 18% |
| 1 Year: | 99% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|